Genzyme Tissue Repair's TGF-beta2 sponge evaluated in phase II diabetic foot ulcers Sep. 3, 1999 No Comments
ACS news: new compounds from Merck & Co. potently and selectively inhibit 5alpha-reductase type 1 Sep. 1, 1999 No Comments
AGN-194310, a high-affinity RAR antagonist for treating retinoid-induced toxicities Sep. 1, 1999 No Comments
Ortec requests FDA permission to initiate CCS trial for diabetic ulcer therapy Aug. 31, 1999 No Comments
Yoshitomi discloses cytokine production inhibitors for treating and preventing allergic reactions Aug. 25, 1999 No Comments
RSS